VioQuest Pharmaceuticals Inc
VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company's products also consist of VQD-002, a nucleoside analog tha… Read more
VioQuest Pharmaceuticals Inc (VOQP) - Total Liabilities
Latest total liabilities as of June 2008: $6.85 Million USD
Based on the latest financial reports, VioQuest Pharmaceuticals Inc (VOQP) has total liabilities worth $6.85 Million USD as of June 2008.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
VioQuest Pharmaceuticals Inc - Total Liabilities Trend (1995–2007)
This chart illustrates how VioQuest Pharmaceuticals Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
VioQuest Pharmaceuticals Inc Competitors by Total Liabilities
The table below lists competitors of VioQuest Pharmaceuticals Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
American Graphite Technologies Inc
PINK:AGIN
|
USA | $284.00K |
|
US Solar Fund PLC
LSE:USFP
|
UK | GBX1.46 Million |
|
Regnum Corp
PINK:RGMP
|
USA | $1.85 Million |
|
Manila Bulletin Publishing Corp
PSE:MB
|
Philippines | ₱1.91 Billion |
Liability Composition Analysis (1995–2007)
This chart breaks down VioQuest Pharmaceuticals Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 5.82 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how VioQuest Pharmaceuticals Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for VioQuest Pharmaceuticals Inc (1995–2007)
The table below shows the annual total liabilities of VioQuest Pharmaceuticals Inc from 1995 to 2007.
| Year | Total Liabilities | Change |
|---|---|---|
| 2007-12-31 | $5.84 Million | +95.56% |
| 2006-12-31 | $2.99 Million | +46.43% |
| 2005-12-31 | $2.04 Million | +87.71% |
| 2004-12-31 | $1.09 Million | +42.92% |
| 2003-12-31 | $760.52K | +475.16% |
| 2002-12-31 | $132.23K | -48.40% |
| 2001-12-31 | $256.24K | +61.85% |
| 2000-12-31 | $158.31K | +0.01% |
| 1999-12-31 | $158.30K | +17.21% |
| 1998-12-31 | $135.06K | -3.99% |
| 1997-12-31 | $140.68K | -17.55% |
| 1996-12-31 | $170.62K | -3.65% |
| 1995-12-31 | $177.08K | -- |